FDANonrulemakingFDA-2022-D-1253
Who commented on this docket
Laser-Assisted In Situ Keratomileusis (LASIK) Lasers – Patient Labeling Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
1 organizations filed 1 public comment on Laser-Assisted In Situ Keratomileusis (LASIK) Lasers – Patient Labeling Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability, at the Food and Drug Administration. The comment window closed 1341d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 1341d ago
Commenters (1)
- Advanced Medical Technology Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.